These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 214127)

  • 41. Regulation of cyclic nucleotide phosphodiesterase activity in rhesus fetal muscle.
    Beatty CH; Herrington PT; Bocek RM
    Biol Neonate; 1977; 32(1-2):33-42. PubMed ID: 198031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclic nucleotide phosphodiesterase from Spinacea oleracea L: subcellular distribution and properties [proceedings].
    Edwards M; Brown EG; Newton RP; Smith CJ
    Biochem Soc Trans; 1977; 5(4):975-7. PubMed ID: 199507
    [No Abstract]   [Full Text] [Related]  

  • 43. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides.
    Davis CW; Daly JW
    Mol Pharmacol; 1980 Mar; 17(2):206-11. PubMed ID: 6248757
    [No Abstract]   [Full Text] [Related]  

  • 45. Cyclic nucleotide phosphodiesterase in rat parotid gland.
    Yokoyama N; Abe M; Furuyama S
    Can J Physiol Pharmacol; 1981 Mar; 59(3):293-9. PubMed ID: 6261905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclic nucleotide phosphodiesterase activity: histochemical and cytochemical methods.
    Ueno S; Ueck M
    Methods Enzymol; 1988; 159():477-89. PubMed ID: 2842613
    [No Abstract]   [Full Text] [Related]  

  • 47. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
    Murray F; MacLean MR; Pyne NJ
    Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclic 3':5'-nucleotide phosphodiesterase determined in various human tissues by DEAE-cellulose chromatography.
    Hidaka H; Yamaki T; Ochiai Y; Asano T; Yamabe H
    Biochim Biophys Acta; 1977 Oct; 484(2):398-407. PubMed ID: 199262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some cardio- or vaso-active butenolide derivatives.
    Némoz G; Prigent AF; Picq M; Pacheco H
    Biochem Pharmacol; 1982 Nov; 31(21):3353-8. PubMed ID: 6293510
    [No Abstract]   [Full Text] [Related]  

  • 50. Drosophila cyclic nucleotide phosphodiesterases.
    Davis RL; Kauvar LM
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():393-402. PubMed ID: 6326533
    [No Abstract]   [Full Text] [Related]  

  • 51. Chromatographic behavior of cyclic 3',5'-nucleotide phosphodiesterases on columns of immobilized inhibitors.
    Mohindru A; Chenet A; Rhoads AR
    Biochemistry; 1978 Aug; 17(16):3297-304. PubMed ID: 80229
    [No Abstract]   [Full Text] [Related]  

  • 52. Inhibition cyclic nucleotide phosphodiesterase by FPL 55712, an SRS-A antagonist.
    Chasin M; Scott C
    Biochem Pharmacol; 1978; 27(16):2065-7. PubMed ID: 214090
    [No Abstract]   [Full Text] [Related]  

  • 53. Adenylate cyclase, cyclic nucleotide phosphodiesterase, and phosphorylase activity of cardiomyopathic hamster hearts.
    Sulakhe SJ; Russell BL; Sulakhe PV
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():359-65. PubMed ID: 201998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclic nucleotide phosphodiesterases.
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():1-416. PubMed ID: 6326516
    [No Abstract]   [Full Text] [Related]  

  • 55. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
    Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF
    J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calmodulin and cyclic nucleotide-phosphodiesterase activities in rat mammary gland during the lactogenic cycle.
    Pizarro M; Puente J; Sapag-Hagar M
    FEBS Lett; 1981 Dec; 136(1):127-30. PubMed ID: 6274696
    [No Abstract]   [Full Text] [Related]  

  • 57. Adrenal medullary cyclic nucleotide phosphodiesterase.--Regulatory properties of three enzyme activities.
    Sitaramayya A; Campbell JA; Siegel FL
    J Neurochem; 1978 Jun; 30(6):1281-5. PubMed ID: 209131
    [No Abstract]   [Full Text] [Related]  

  • 58. The distribution of cyclic nucleotide phosphodiesterase in the hypothalamus.
    Howlett AC; Breckenridge BM
    J Neurochem; 1978 Jul; 31(1):321-7. PubMed ID: 209146
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies on the soluble phosphodiesterases of chicken gizzard smooth muscle.
    Birnbaum RJ; Head JF
    Biochem J; 1983 Dec; 215(3):627-36. PubMed ID: 6318728
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of the cyclic nucleotide phosphodiesterase from rat heart cytosol by phospholipase C.
    Prigent AF; Némoz G; Picq M; Dubois M; Pacheco H
    Biochem Biophys Res Commun; 1984 Feb; 119(1):236-44. PubMed ID: 6322779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.